Patents by Inventor Anton Baumberger

Anton Baumberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10314784
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: June 11, 2019
    Assignee: Novartis AG
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20160081934
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 24, 2016
    Applicant: Novartis AG
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephen Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20150224194
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: April 21, 2015
    Publication date: August 13, 2015
    Applicant: Novartis AG
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Patent number: 8182792
    Abstract: A process for micronization of pharmaceutically active agents.
    Type: Grant
    Filed: March 22, 2005
    Date of Patent: May 22, 2012
    Assignee: Novartis AG
    Inventors: Gerhard Muhrer, Ricardo Schneeberger, Wolfgang Wirth, Anton Baumberger
  • Publication number: 20120065174
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: October 12, 2011
    Publication date: March 15, 2012
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20090209502
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: June 28, 2007
    Publication date: August 20, 2009
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20080026981
    Abstract: A process for micronization of pharmaceutically active agents.
    Type: Application
    Filed: March 22, 2005
    Publication date: January 31, 2008
    Inventors: Gerhard Muhrer, Ricardo Schneeberger, Wolfgang Wirth, Anton Baumberger